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1  | INTRODUC TION
Periodically, large, repeated cross‐sectional and panel studies need 
to be updated and survey items changed to improve the quality of 
the information collected, reduce data collection cost, improve com‐
parability with other surveys, and/or maintain the relevance of the 
questions asked.1 Because respondents infer the meaning of a ques‐
tion from the words used, response categories, preceding questions, 
and their own previous answers,2‐4 even small changes to ques‐
tion wording (content) or question order (preceding question) can 
influence survey responses.5 These influences may translate into 
a substantial impact on the marginal distributions of measures (ie, 
response tendency) and the magnitude of the relationship among 
survey items.6 In situations when scores have important conse‐
quences, such as when survey results are publicly reported or used 
to determine reimbursements for the entities being surveyed about, 
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Abstract
Objective: To assess the effect of changing survey questions on plan‐level patient 
experience measures and ratings.
Data Source: 2015 Medicare Advantage CAHPS Survey respondents.
Study Design: Ninety three randomly selected beneficiaries in each of 40 MA plans 
received a revised (5.0) CAHPS survey; 38 832 beneficiaries received version 4.0. 
Linear mixed‐effect regression predicted CAHPS measures from fixed effects for 
survey version and beneficiary characteristics and random effects for plan and plan‐
by‐version random slope.
Principal Findings: Response rates were 42 percent for both versions. Removal of 
“try to” from screeners increased the percentage of respondents eligible for fol‐
low‐up questions. Version 5.0 caused a small increase (1‐3 points on a 0‐100 scale, 
P < 0.05) in the mean of three altered measures and a moderate increase (>3 points) 
in one. There was a small statistically significant increase in two unaltered measures. 
These changes were uniform across plans, so there would be no expected change 
compared to results using the legacy survey in the score distributions other than 
uniform mean shifts, and no expected effect on summary measures.
Conclusions: These analyses illustrate how to assess the impact of seemingly minor 
survey modifications for other national surveys considering changes and highlight 
the importance of screeners in instrument design.
K E Y W O R D S
Medicare, patient, survey research and questionnaire design
2  |     Health Services Research BECKETT ET al.
it is important to assess the potential impact of changes in survey 
forms before implementing the change.
The Agency for Healthcare Research and Quality (AHRQ) spon‐
sored the development of the CAHPS health plan surveys.7 Since 
2000, the Centers for Medicare and Medicaid Services (CMS) has 
annually collected and publicly reported data on beneficiaries’ ex‐
periences with care using the Consumer Assessment of Healthcare 
Providers and Systems (CAHPS) health plan surveys as a base. The 
Medicare Advantage (MA) CAHPS survey is based on the original 
CAHPS Health Plan Survey and also asks about aspects of beneficia‐
ries’ health care experiences that are specific to the managed care 
form of Medicare, prescription drug provision, and other issues of 
Medicare policy. Since 2012, health plans’ MA‐CAHPS scores have 
been used to calculate summary Star Ratings, which are used for 
incentive payments to MA health and prescription drug plans.8,9
From 2007 until the time of this experiment (2015), the MA‐
CAHPS survey was based on version 4.0 CAHPS Health Plan Survey. 
CAHPS surveys undergo periodic refinement and updates to survey 
versions to improve the comprehensibility and quality of information 
collected. To improve the comparability of MA‐CAHPS with other 
CAHPS surveys, CMS considered transitioning the MA‐CAHPS sur‐
vey to version 5.0 Health Plan Survey following its release in 2012. 
Most proposed changes were intended to simplify the items and 
make them consistent with questions in other CAHPS surveys.10
Because MA‐CAHPS surveys are used to calculate Star Ratings 
and plan incentive payments, there was concern about the poten‐
tial impact of changes in the survey. To address this, we conducted 
a randomized experiment to evaluate the potential impact on plan 
scores from changes to content, screeners, and preceding questions 
in the MA‐CAHPS surveys associated with the transition scheduled 
to occur in 2017. Specifically, we measured the effects on improve‐
ment scores and relative changes that would re‐rank plan perfor‐
mance on which incentive payments are based.
2  | METHODS
2.1 | Data collection
We conducted a split‐sample field test employing the same mixed‐
mode data collection procedures for both samples (as described 
in MA‐PDPCAHPS.org).11 Because of budget limitations, the 5.0 
survey version was administered in English only, whereas the 4.0 
survey, which represented that year's full‐scale, official national im‐
plementation, was conducted in English, Spanish, and Chinese.
The study was approved by the Human Subjects Protection 
Committee of the RAND Corporation.
2.2 | CAHPS measures
MA survey questions are typically grouped into seven compos‐
ites for public reporting: Getting Needed Care, Getting Care Quickly, 
Doctor Communication, Customer Service, Care Coordination, Getting 
Needed Prescription Drugs, and Getting Information about Prescription 
Drugs. In addition, there are five publicly reported 0‐10 ratings 
(Rating of Personal Doctor, Rating of Specialist, Rating of Health Plan, 
Rating of Health Care Quality, and Rating of Drug Plan) and two single‐
item measures: Flu Immunization and Pneumonia Vaccine (both asked 
of beneficiaries aged 65 or older).
Following a common approach for CAHPS data,12 we linearly 
transformed scores x from their original a‐to‐b scale to a 0 (lowest)‐
to‐100 (highest) possible range, y = 100 × (x−a)/(b−a), to facilitate 
comparison of results from different variables. No CAHPS scores 
were imputed. We characterized differences exceeding three points 
on 0‐100 scales (or 3 percentage points) as moderate;13 we further 
characterized differences <1 point as very small, and differences of 
1‐3 points as small.
2.3 | Beneficiary characteristics
We adjusted MA‐CAHPS measures for differences in responses as‐
sociated with case‐mix adjusters.14,15 We also adjusted for Spanish 
language and survey‐based race/ethnicity to account for the re‐
striction of the 5.0 survey administration to English language in this 
experiment. Missing case mix adjusters (4 percent–7 percent) were 
mean‐imputed within contracts (the CMS term for the reporting 
units of MA plans; hereafter “plans”). All analyses employed post‐
stratification weights accounting for plan‐level sample design and 
nonresponse. Analyses were performed using SAS software version 
9.4 and accounted for the design effects of weights using the lineari‐
zation method implemented by SAS survey procedures.16
2.4 | Sample
We selected a stratified random sample of plans within strata of 
scores on publicly‐reported patient experience measures (imple‐
mented as a systematic sample within a sorted list) to improve the 
precision of reliability estimates by ensuring that the distribution of 
plan‐level scores was similar to those for the full set of plans. For each 
of the 40 MA plans in the experiment, we first selected a random 
sample of beneficiaries for the required 2015 MA‐CAHPS 4.0 survey 
(38 832 beneficiaries total) and then selected an additional random 
sample of 93 beneficiaries per plan (3720 beneficiaries total) to re‐
ceive the 5.0 version of the survey. Both 4.0 and 5.0 surveys were 
administered by the CMS‐approved vendor selected and authorized 
by each plan. 5.0 survey responses were not used in reported scores 
or Star Ratings for the 2015 survey year but were compared to re‐
sponses to the legacy 4.0 surveys from the same plans.
2.5 | Statistical analyses
2.5.1 | Version effects on response rate
We computed the version 4.0 and 5.0 response rates and tested for 
significant differences in three ways: unadjusted, adjusted for plan 
effects, and adjusted for both plans and beneficiary characteristics 
available through administrative data (age [18‐24, 10‐year bands for 
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ages 25‐64, five‐year bands for ages 65‐84, 85+]; gender; urbanicity 
as measured by Beale code ranging from 1 = most urban to 9 = least 
urban, with values of 5 or greater coded as 5; SSA‐based administra‐
tive race/ethnicity [Hispanic, White, Black, Asian, American Indian‐
Alaska Native/Other/Unknown]; and indicators of low income 
[receipt of Low Income Supplement, dual eligibility for Medicaid, 
neither]).
2.5.2 | Version effects on unadjusted differences 
in questions
We computed the mean for items used in CAHPS composite meas‐
ures by version and their differences by survey version. We used 
two‐sample t tests and chi‐square tests to test for the statistical 
significance of differences in the ordinal item means and unordered 
item frequency distributions, respectively. We summarized version 
effects based on type of change (change to content, screener, or pre‐
ceding question).
2.5.3 | Version effects on health plans’ case-mix 
adjusted scores
For 14 CAHPS measures (composites, ratings, and single‐item meas‐
ures), we estimated two primary sets of linear regression models. 
The primary model predicted mean CAHPS scores from an indicator 
of survey version, random plan intercepts, and standard MA‐CAHPS 
case mix adjusters: age, education, general health, mental health, 
proxy assistance, and low‐income indicators. A second model added 
random plan effects for the version 5.0—version 4.0 difference to 
test the heterogeneity of version effects across plans.
Substantially and statistically significantly lower plan‐level reli‐
ability in 5.0 than in 4.0 or evidence of substantially heterogeneous 
effects across plans would be cause for concern. Because CAHPS 
surveys help consumers compare plans, plan‐level reliability is key. 
In the absence of changes in reliability, no significant main effect 
of 4.0/5.0 changes on overall means would be consistent with no 
effects on Star Ratings and support adopting the 5.0 version. In con‐
trast, a statistically significant main effect would suggest a possible 
effect on Star Ratings, depending on whether the effect differed 
significantly across plans. To measure reliability for the two survey 
versions, plan‐level intraclass correlations (ICCs) were estimated for 
the 4.0/5.0 versions of each measure. The ICCs were estimated from 
separate models for versions 4.0 and 5.0 that included random plan 
intercepts and fixed effects for beneficiary characteristics. The z‐
statistic for version differences in ICCs was computed as the differ‐
ence between the version 5.0 and version 4.0 ICCs over the square 
root of the sum of the squares of the associated ICC standard errors.
3  | RESULTS
The response rate was 42 perfect for both versions of the sur‐
vey. Compared to version 4.0 respondents, version 5.0 respondents 
were more educated (54 percent had at least some college, com‐
pared to 49 percent of version 4.0 respondents) and less likely to 
be Hispanic/Latino (6 percent vs. 8 percent), reflecting the use of 
Spanish language surveys in the legacy version 4.0 administration 
but not the 5.0 sample.
3.1 | Unadjusted version effects on items used in 
composite measures
Nineteen MA survey items had content changes, screener changes, 
or changes to the immediately preceding item (see Appendix 
Table S1 for details). The response distribution differed significantly 
by version for 14 of the 19 changed items.
The word changes that most consistently affected response dis‐
tributions applied to one or more screeners, so we focus on these 
items in Table 1. Five screener items (Q35, Q40, Q56, Q59, and Q61) 
were changed by removing “try to” from the wording (eg, Q35 “Did 
you make any appointments to see a specialist?” vs. “Did you try to 
make any appointments to see a specialist?”). Removal of “try to” was 
consistently associated with an 8 to 29 percentage point increase 
in endorsement rates (P < 0.001 for all). Specifically, a higher pro‐
portion of people reported that they made appointments to see a 
specialist than said that they had tried to make an appointment (Q35: 
61 percent vs. 55 percent), get information or help from customer 
service than tried to get information or help (Q40: 45 percent vs. 30 
percent), and get information or help about prescriptions from pre‐
scription drug plan's customer service than tried to get information 
or help about prescriptions (Q56: 31 percent vs. 17 percent). The 
largest endorsement rate increases related to getting from prescrip‐
tion drug plans information about which medicines were covered 
(Q59: 44 percent vs. 15 percent) and about how much one would 
have to pay for prescription medicines (Q61: 46 percent vs. 18 per‐
cent) rather than “trying to” get such information. In each case, the 
“try to” group may be a subset of those who got information from 
customer service; those who got information included people that 
did not try to get it (passive) along with those who tried (active). The 
subset of respondents that actively tried to get information about 
health plan (Q41 and Q42) or about prescription drug coverage 
(Q57, Q58, Q60, and Q62) from customer service (version 4.0) con‐
sistently reported worse experiences than the larger group that got 
information (version 5.0). The subset of respondents that actively 
tried to get an appointment for specialty care (version 4.0) did not 
differ from the larger group that got an appointment (version 5.0) in 
terms of getting an appointment (Q36: 3.7 vs. 3.7; P > 0.05) but gave 
the specialist a lower rating (Q38: 8.92 vs. 9.03; P < 0.05; Appendix 
Table 1).
One screener regarding appointments for routine care was 
changed (Q5). The version 4.0 survey referred to routine care as “not 
counting the times you needed care right away,” whereas the ver‐
sion 5.0 survey referred directly to “a check‐up or routine care.” This 
change resulted in an increase in the proportion of respondents who 
reported making an appointment for routine care (Q5: 86 percent 
vs. 78 percent; P < 0.001). Endorsement rates for unaltered screener 
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items did not significantly differ between versions except for Q37 
(personal doctor ordered a blood test, x‐ray, or other test), which 
increased two percentage points (from 88 percent to 90 percent, 
P < 0.05).
3.2 | Version effects on CAHPS measures
As shown in Table 2, three composites had content changes to one or 
more of their constituent items in version 5.0 (Getting Neded Care, 
TA B L E  1   Screener endorsement rates, by survey version
Star Rating 
measure
Annotated Version 5.0 question wording (Edits are deliber-
ate and reflect changes from Version 4.0)
Type of 
change to 
item
Means (standard devia-
tions)/Percent yes Significance of dif-
ference between 
survey versions**5.0a  4.0b 
Getting Needed 
Care
Q35. In the last 6 mo, did you try to make any appointments 
to see a specialist? [Yes/No]
Content 
change
61% 55% *** 
Getting Care 
Quickly
Q3. In the last 6 mo, did you have an illness, injury, or condi‐
tion that needed care right away in a clinic, emergency 
room, or doctor's office? [Yes/No] 
Unaltered 34% 33%
Q5. In the last 6 mo, not counting the times you needed 
care right away, did you make any appointments for your 
health a check-up or routine care at a doctor's office or 
clinic? [Yes/No] 
Content 
change
86% 78% *** 
Doctor 
Communication
Q14. A personal doctor is the one you would see if you 
need a check‐up, want advice about a health problem, or 
get sick or hurt. Do you have a personal doctor? [Yes/No] 
Unaltered 95.0% 94.0%
Q15. In the last 6 mo, how many times did you visit your 
personal doctor to get care for yourself? [None/1/2/3/4/5 
to 9/10 or more] 
Unaltered 1.80 
(0.34)
1.80 
(0.37)
Customer 
Service
Q40. In the last 6 mo, did you try to get information or help 
from your health plan's customer service? [Yes/No] 
Content 
change
45% 30% *** 
Q43. In the last 6 mo, did your health plan give you any 
forms to fill out? [Yes/No]
Unaltered 22% 21%
Getting 
Information 
about 
Prescription 
Drug Coverage
Q56. You contact customer service to get information 
about what is covered and how to use a drug plan. In the 
last 6 mo, did you try to get information or help about 
prescriptions from your prescription drug plan's customer 
service? [Yes/No] 
Content 
change
31% 17% *** 
Q59. In the last 6 mo, did you try to get information from 
your prescription drug plan about which prescription medi‐
cines were covered? [Yes/No] If No, Go to Question 61.
Content 
change
44% 15% *** 
Q61. In the last 6 mo, did you try to get information from 
your prescription drug plan about how much you would 
have to pay for your prescription medicines? [Yes/No] 
Content 
change
46% 18% *** 
Care 
Coordination
Q22. In the last 6 mo, did your personal doctor order a 
blood test, x‐ray or other test for you? [Yes/No] 
Unaltered 90% 88% * 
Q25. In the last 6 mo, did you take any prescription medi‐
cine? [Yes/No]
Unaltered 96% 96%
Q30. In the last 6 mo, did you get care from more than one 
kind of health care provider or use more than one kind of 
health care service? [Yes/No]
Unaltered 63% 63%
Q31. In the last 6 mo, did you need help from anyone in 
your personal doctor's office to manage your care among 
these different providers and services? [Yes/No] 
Unaltered 34% 33%
Q37. How many specialists have you seen in the last 6 mo? 
[None/1 specialist/2/3/4/5 or more specialists]
Unaltered 1.86 
(1.08)
1.84 
(1.09)
Note: Bolded text denotes words added for version 5; lined out text was deleted for version 5.
aN = 1550.
bN = 16 338.
*P < 0.05; **P < 0.01; ***P < 0.001 for difference between survey versions (chi‐square tests for frequency distributions of unordered items, two‐sam‐
ple t tests for ordinal item means).
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Getting Care Quickly, and Getting Information about Prescription 
Drug Coverage). Two additional composites had screener changes 
to one or more items (customer service and care coordination), as 
did the global specialist rating. The 5.0 version resulted in more fa‐
vorable reports than the 4.0 version, with six significantly positive 
(P < 0.05) differences from version 4.0 (getting care quickly, doctor 
communication, customer service, care coordination, rating of spe‐
cialist, and rating of health care quality) and no significantly negative 
differences. Of the six reportable measures with change to content, 
screener changes, or the immediately preceding item, one had mod‐
erately significant increase in adjusted scores (customer service: 
+3.73 points) and three had small increases: specialist rating (+1.29), 
getting care quickly (+2.91), and care coordination (+1.27). In addi‐
tion, two measures that did not differ between survey versions had 
significant increases: doctor communication (+1.34) and global rating 
of care (+1.09). Adjusted increases on CAHPS measures are not iden‐
tical to but are consistent with the unadjusted item‐level differences.
There were no statistically significant version‐by‐plan interac‐
tion variance components (results not shown). In other words, the 
changes were uniform across plans. Across items, the mean mini‐
mum‐detectable plan standard deviation in the version 5.0 effect 
was 2.7, a moderate effect for patient experience measures.13 There 
were no significant differences in plan‐level reliability between ver‐
sions 4.0 and 5.0 (results not shown).
TA B L E  2   Results of mixed models for version differences in reportable measures within MA plans
Reportable measure
Difference between V4.0 and V5.0a, by 
V5.0 question number
Measure used in 
Star Ratings N
Adjusted mean of V5.0—V4.0 
measures (standard error) on 
0-100 scaleb
Getting Needed Care Q13: Screener deleted/question order 
changed
Yes 11,989 −0.45	(0.65)
Q36: Screener and item wording changed
Getting Care Quickly Q4: Changed wording Yes 15,365 2.91 (0.70)***
Q6: Screener and item wording changed
Doctor Communication Q14‐Q19: Unaltered No 14,060 1.34 (0.48)**
Customer Service Q41: Screener changed Yes 7,158 3.73 (0.89)***
Q42: Screener changed
Q44: Unaltered
Care Coordination Q21‐Q24: Screener changed Q26, 
Q32, Q39: Unaltered
Yes 14,539 1.27 (0.54)*
Getting Needed 
Prescription Drugs
Q68, Q70, Q72: Unaltered Yes 14,431 −0.03	(0.62)
Getting Information 
about Prescription 
Drug Coverage
Q57: Screener (Q56) changed No 4,342 2.18 (1.19)
Q58: Changed wording/ Screener 
(Q56) changed
Q60: Screener (Q59) changed
Q62: Screener (Q61) changed 
Rating of Personal 
Doctor
Q20: Unaltered No 13,929 0.75 (0.44)
Rating of Specialist Q35: Screener changed No 9,484 1.29 (0.57)*
Rating of Health Plan Q45: Unaltered Yes 16,825 −0.33	(0.49)
Rating of Health Care 
Quality
Q12: Unaltered Yes 17,098 1.09 (0.49)*
Rating of drug plan Q73: Unaltered Yes 14,959 0.36 (0.59)
Flu Immunization (age 
65 + )
Q97: Unaltered Yes 15,547 1.32 (1.20)
Pneumonia 
Immunization (age 
65 + )
Q98: Unaltered No 14,707 0.71 (1.23)
Notes: Significant differences of > 1‐3 points represent small differences and appear in italics; differences > 3 points represent moderate differences 
and are underlined.
All measures are on a 0‐100 scale.
aFor composite measures, the indicated change applies to one or more constituent items. 
bModels are adjusted for beneficiary characteristics (race/ethnicity, survey language, age, education, general health, mental health, proxy assistance, 
and low‐income indicators) and include random intercepts for plans. 
*P < 0.05, **P < 0.01, ***P < 0.001 for test for difference from zero.
6  |     Health Services Research BECKETT ET al.
4  | DISCUSSION
Some seemingly minor word changes were significantly associated 
with who answered survey items and how they did so. In particular, 
most items were affected by removing “try to” from questions re‐
lated to getting information from customer service or making an ap‐
pointment. Beneficiaries asked if they had tried to get information or 
tried to make an appointment are a subset of those asked if they got 
information or made an appointment. In general, the “try to” group 
reported worse experiences. This may be because the “try to” group 
has greater information, more appointment needs, or higher expec‐
tations than the larger group of beneficiaries who got information 
or made an appointment. Alternatively, some may interpret “try to” 
as meaning tried but failed. We are unable to test these hypotheses 
here, but future cognitive testing and other survey research may 
want to carefully probe how potential respondents interpret “try to” 
in different contents. Other measures that were unchanged them‐
selves, such as the global rating of care, also had slightly increased 
mean scores, perhaps because of context effects.
Our results also suggest that the effect of 5.0 vs. 4.0 in subse‐
quent administrations should be a constant upward shift for every 
plan and that any deviation from that trend would be random vari‐
ation, although there was insufficient power to detect small plan‐
level differences. Star assignments are based on four inputs, each 
unaffected by a linear transformation of scores across plans, such as 
that seen here: (a) percentile rank of the plan; (b) significance testing 
vs. overall mean; (c) plan‐level reliability (used in categories); and (d) 
standard errors (whether they fall below 15th percentile or above 
80th percentile by at least one standard error). Since there are no 
fixed thresholds for Star Ratings and they are based on the actual 
distribution of scores, we concluded that there should be no shifts in 
Star Ratings in the transition between survey versions. While scores 
on the 0‐100 scale will be higher on average even if no true improve‐
ment occurs, any changes in Star Ratings would be due to factors 
other than the 4.0/5.0 transition. These findings provided a basis for 
CMS's transition from version 4.0 to 5.0 of the MA and PDP CAHPS 
survey in 2017.
Because absolute scores are higher with version 5.0, Star Rating 
improvement scores could have been affected by the survey instru‐
ment change, except that CMS removes measures with specification 
changes from the improvement score for two years (until the two 
years being compared again have identical specifications). Similarly, 
plans assessing trends in their own CAHPS scores should adjust for 
potential changes due to differences in survey versions. Methods for 
such adjustments have been presented elsewhere.17,18 If maintaining 
trending for absolute scores is of interest, the differences from the 
randomized version experiment presented in Table 2 could be used 
as trending adjustments.
Our study is not without limitations. Though our results do not 
suggest bias in our comparisons across plans or in the associated 
Star Ratings, other biases may be apparent if ratings and reports 
were compared over time without adjustment for the differences 
estimated here.
Survey experiments such as the one conducted here may pro‐
vide important evidence regarding the effect of changing survey 
questions.19 The split‐sample field experiment and analysis de‐
scribed here might serve as a model for assessing the impact of 
potential changes to national surveys, especially after they have 
entered a high‐stakes environment and the data collected have 
important financial, policy, or programmatic implications, such 
as with the MA‐CAHPS Survey. It could also be used to evaluate 
the need to bridge approaches such as rescaling to ensure the 
comparability of measures across survey versions and changing 
populations.
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ENDNOTE
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combined for analysis due to small sample sizes. 
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